Cargando…

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus

Recent studies suggested that nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiac tachyarrhythmias (mainly atrial fibrillation) in patients with and without type 2 diabetes mellitus. The aim of this study was to examine whether an association also exists between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mantovani, Alessandro, Rigolon, Riccardo, Pichiri, Isabella, Bonapace, Stefano, Morani, Giovanni, Zoppini, Giacomo, Bonora, Enzo, Targher, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628831/ https://www.ncbi.nlm.nih.gov/pubmed/28981521 http://dx.doi.org/10.1371/journal.pone.0185459

Ejemplares similares

Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2015)

Nonalcoholic Fatty Liver Disease Is Associated with Aortic Valve Sclerosis in Patients with Type 2 Diabetes Mellitus
por: Bonapace, Stefano, et al.
Publicado: (2014)

Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance
por: Cacciatori, Vittorio, et al.
Publicado: (2017)

Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure
por: Valbusa, Filippo, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
por: Bonapace, Stefano, et al.
Publicado: (2012)

Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function
por: Zoppini, Giacomo, et al.
Publicado: (2012)

Glycated Haemoglobin Is Inversely Related to Serum Vitamin D Levels in Type 2 Diabetic Patients
por: Zoppini, Giacomo, et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure
por: Valbusa, Filippo, et al.
Publicado: (2016)

Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2018)

The E/e’ ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies
por: Zoppini, Giacomo, et al.
Publicado: (2018)

Aortic and Mitral Annular Calcifications Are Predictive of All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes
por: Rossi, Andrea, et al.
Publicado: (2012)

Lower levels of 25-hydroxyvitamin D(3) are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2015)

Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes
por: Targher, Giovanni, et al.
Publicado: (2013)

Comparison of Two Creatinine-Based Estimating Equations in Predicting All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes
por: Targher, Giovanni, et al.
Publicado: (2012)

High-Normal HbA(1c) Is a Strong Predictor of Type 2 Diabetes in the General Population
por: Bonora, Enzo, et al.
Publicado: (2011)

Elevated Serum Uric Acid Concentrations Independently Predict Cardiovascular Mortality in Type 2 Diabetic Patients
por: Zoppini, Giacomo, et al.
Publicado: (2009)

The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2016)

Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure
por: Inciardi, Riccardo M., et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2021)

What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease
por: Targher, Giovanni
Publicado: (2020)

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease – a growing public health problem
por: Mikolašević, Ivana, et al.
Publicado: (2021)

Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
por: Mantovani, Alessandro, et al.
Publicado: (2016)

Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI‐HF trial
por: Targher, Giovanni, et al.
Publicado: (2020)

Diabetes as a cause of death across different COVID-19 epidemic waves
por: Fedeli, Ugo, et al.
Publicado: (2022)

SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people
por: Bonora, Enzo, et al.
Publicado: (2021)

Primary cutaneous B-cell lymphoma and chronic leg ulcers in a patient with type 2 diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2017)

Controlling nutritional status score predicts 2-year outcomes in elderly patients admitted for acute heart failure
por: Agnoletti, Davide, et al.
Publicado: (2023)

Increased Pulse Pressure Independently Predicts Incident Atrial Fibrillation in Patients With Type 2 Diabetes
por: Valbusa, Filippo, et al.
Publicado: (2012)

Severe hypoglycemia in patients with known diabetes requiring emergency department care: A report from an Italian multicenter study
por: Mantovani, Alessandro, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease (NAFLD) and Risk of Cardiac Arrhythmias: A New Aspect of the Liver-heart Axis
por: Mantovani, Alessandro
Publicado: (2017)

Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis
por: Maurelli, Martina, et al.
Publicado: (2023)

Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9
por: Bonora, Enzo, et al.
Publicado: (2020)

Increased aortic stiffness in adults with chronic indeterminate Chagas disease
por: Valbusa, Filippo, et al.
Publicado: (2019)

Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum
por: Tavaglione, Federica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9q2tk1v4mhqjlkvo7kd7tkhvut